Streetbeat News

Products Services

AMST

Amesite Inc. has entered into a five-year partnership with Joliet Junior College to provide an advanced learning platform. This collaboration aims to enhance educational experiences through Amesite's innovative technology solutions.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:14 pm

AMD

AMD CEO Lisa Su highlighted AI as the 'most important' technology of the last 50 years, emphasizing its potential for growth and AMD's efforts to capture market share through cloud and edge computing partnerships and AI-powered PCs. Su anticipates 'tremendous growth' in AI over the next three to five years, aiming to make AI accessible to everyone through a range of products.

Portfolio Pulse from Adam Eckert

March 11, 2024 | 9:13 pm

GSM

Ferroglobe and Coreshell have signed a Memorandum of Understanding (MoU) to produce the first battery-grade metallurgical silicon for electric vehicles (EVs), aiming for low-cost, high-range EV batteries in line with the U.S. Inflation Reduction Act.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:12 pm

MRAM

Everspin Technologies has applied for the CHIPS Incentives Program to expand its 200mm MRAM capacity and enhance long-term R&D IP capability.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:08 pm

RUM

Rumble has publicly launched Rumble Cloud, aiming to offer businesses an alternative to incumbent hyperscalers by providing fair pricing, avoiding vendor lock-in, and ensuring freedom from censorship.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:07 pm

DIS

FOX

PARA

WBD

XLC

'Oppenheimer' dominated the 2024 Academy Awards, winning seven Oscars, including Best Picture. 'Poor Things' won three awards, with Emma Stone receiving Best Actress. Paramount Global, Warner Bros Discovery, Fox Corp, and Walt Disney Co saw stock gains post-awards, while the Communication Services Select Sector SPDR Fund remained flat.

Portfolio Pulse from Neil Dennis

March 11, 2024 | 8:48 pm

DVA

The American Diabetes Association (ADA) and DaVita (NYSE:DVA) have expanded their multi-year collaboration to advance chronic disease prevention, focusing on diabetes and chronic kidney disease (CKD). This expansion, announced during National Kidney Month, includes a $1.5 million contribution from DaVita to the ADA's initiatives. The partnership aims to increase awareness, education, and support, especially in communities of color disproportionately affected by these conditions. Efforts include creating educational materials, a dietitian program, and sponsoring ADA's State of Diabetes events.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:44 pm

ACAD

Acadia Pharmaceuticals' stock is trading lower following the announcement that its Phase 3 ADVANCE-2 trial of pimavanserin for treating negative symptoms of schizophrenia failed to meet the primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:40 pm

AVO

Mission Produce anticipates a slight sequential increase in avocado pricing, projecting a 10-15% rise from the Q2 2023 average of $1.30 per pound.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:36 pm

JNJ

Johnson & Johnson has submitted a Supplemental Biologics License Application to the FDA for the approval of TREMFYA (Guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:35 pm